United Biomedical Inc. became the second Taiwanese COVID-19 vaccine developer to receive Food and Drug Administration (FDA) approval to begin a phase 2 clinical trial, the regulator said in statement released on Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Guangfu reconstruction meeting marred by disorder, political spats
10/28/2025 02:28 PM - Business
Hon Hai to invest NT$42 billion in AI computing equipment
10/28/2025 02:17 PM - Business
Taiwan shares close down 0.16%
10/28/2025 01:55 PM - Culture
Documentary on Czech Senate president's visit to Taiwan debuts in Prague
10/28/2025 01:24 PM - Politics
Taiwan launches global initiative on security of undersea cables
10/28/2025 11:57 AM